193PPrognostic implication of inflammation-based scores in patients with metastatic pancreatic cancer (mPC) treated with first-line nab-paclitaxel plus gemcitabine (AG). (25th November 2018)

Record Type:: Journal Article
Title:: 193PPrognostic implication of inflammation-based scores in patients with metastatic pancreatic cancer (mPC) treated with first-line nab-paclitaxel plus gemcitabine (AG). (25th November 2018)
Main Title:: 193PPrognostic implication of inflammation-based scores in patients with metastatic pancreatic cancer (mPC) treated with first-line nab-paclitaxel plus gemcitabine (AG)
Authors:: Ip, H N N
Hwang, I
Kang, J
Kim, K-P
Jeong, J H
Chang, H-M
Ryoo, B-Y
Yoo, C
Abstract:
Is Part Of:: Annals of oncology. Volume 29(2018)Supplement 9
Journal:: Annals of oncology
Issue:: Volume 29(2018)Supplement 9
Issue Display:: Volume 29, Issue 9 (2018)
Year:: 2018
Volume:: 29
Issue:: 9
Issue Sort Value:: 2018-0029-0009-0000
Page Start:
Page End:
Publication Date:: 2018-11-25
Subjects:: Oncology -- Periodicals
616.992
Journal URLs:: https://www.journals.elsevier.com/annals-of-oncology ↗
http://ukcatalogue.oup.com/ ↗
DOI:: 10.1093/annonc/mdy432.045 ↗
Languages:: English
ISSNs:: 0923-7534
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 1043.320000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 12261.xml